Obesity
Showing NaN - NaN of 53
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019
Obesity Trial in Netherlands, United States (Exilis Implantable Gastric Electrical Stimulation (GES))
Completed
- Obesity
- Exilis Implantable Gastric Electrical Stimulation (GES)
-
Scottsdale, Arizona
- +3 more
Sep 30, 2018
Obesity, Lumbar Spine Surgery Trial in Louisville (Closed-Incision Negative-Pressure Therapy)
Unknown status
- Obesity
- Lumbar Spine Surgery
- Closed-Incision Negative-Pressure Therapy
-
Louisville, KentuckyNorton Leatherman Spine Center
Sep 27, 2018
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study
Terminated
- Obesity
- Overweight
-
Fountain Valley, California
- +10 more
Jun 25, 2018
Obesity Trial in United States (Velneperit 400 mg, Orlistat 120 mg, Orlistat Placebo)
Completed
- Obesity
- Velneperit 400 mg
- +4 more
-
Santa Rosa, California
- +24 more
May 7, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Vestavia Hills, Alabama
- +160 more
Dec 6, 2017
Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Goodyear, Arizona
- +36 more
Sep 29, 2017
Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- +2 more
- liraglutide
- placebo
-
Glendale, California
- +41 more
Sep 29, 2017
Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)
Terminated
- Obesity
- Cardiovascular Diseases
- Naltrexone HCl/Bupropion HCl ER
- Placebo
-
Alexander City, Alabama
- +138 more
Feb 21, 2017
Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)
Terminated
- Type 2 Diabetes
- Obesity
- EndoBarrier
- Sham Procedure
-
Birmingham, Alabama
- +24 more
Dec 2, 2016
Bacterial Infections, Obesity Trial in United States (Clindamycin)
Completed
- Bacterial Infections
- Obesity
-
Chicago, Illinois
- +3 more
Nov 21, 2016
Obesity, Obstructive Sleep Apnea Trial in Louisville (Microcapmicro-stream device with Smart CapnoLine Plus, Microcap
Completed
- Obesity
- Obstructive Sleep Apnea
- Microcapmicro-stream device with Smart CapnoLine Plus
- +2 more
-
Louisville, KentuckyUniversity of Louisville
Jul 18, 2016
Overweight, Obesity Trial in United States (pramlintide acetate, sibutramine, phentermine)
Completed
- Overweight
- Obesity
- pramlintide acetate
- +3 more
-
Birmingham, Alabama
- +15 more
Mar 5, 2015
Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary
Completed
- Obesity
- +2 more
- Naltrexone SR 32 mg/bupropion SR 360 mg/ day
- +2 more
-
Fairhope, Alabama
- +52 more
Nov 18, 2014
Feeding Trial in the Obese Critical Care Population
Completed
- Critical Illness
- Obesity
- enteral formula
-
Lexington, Kentucky
- +1 more
Jan 29, 2014
Obesity Trial in United States (Patient Expectations)
Completed
- Obesity
- Patient Expectations
-
Denver, Colorado
- +11 more
Dec 16, 2013
Obesity Trial in Puerto Rico, United States (Canagliflozin (JNJ-28431754), Placebo)
Completed
- Obesity
- Canagliflozin (JNJ-28431754)
- Placebo
-
Hot Springs, Arkansas
- +35 more
Apr 1, 2013
Obesity Trial in Louisville (IGEL, King airway)
Withdrawn
- Obesity
- IGEL
- King airway
-
Louisville, KentuckyUniversity of Louisville Hospital
Nov 12, 2012
Obesity Trial in Worldwide (CP-945,598 Treatment B, CP-945,598 Treatment A, Placebo)
Terminated
- Obesity
- CP-945,598 Treatment B
- +2 more
-
Peoria, Arizona
- +60 more
Nov 5, 2012
Obesity Trial in Canada, United States (CP-945,598 Treatment A, CP-945,598 Treatment B, Placebo)
Terminated
- Obesity
- CP-945,598 Treatment A
- +2 more
-
Fairhope, Alabama
- +81 more
Nov 5, 2012
Testing the Developmental Origins Hypothesis
Unknown status
- Diabetes
- +2 more
-
New Haven, Connecticut
- +40 more
Mar 1, 2012